Publications by authors named "Stelvio Ballanti"

32Publications

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.

Lancet Haematol 2020 Jun 30;7(6):e456-e468. Epub 2020 Apr 30.

Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(20)30099-5DOI Listing
June 2020

Sensitivity of cutaneous chronic myelomonocytic leukaemia lesions to hypomethylating treatment.

Eur J Dermatol 2017 10;27(5):540-542

Institute of Hematology and Hemato-Oncology Research Centre (CREO), University of Perugia, Perugia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/ejd.2017.3068DOI Listing
October 2017

Updated results of a phase 2 study of panobinostat combined with melphalan, thalidomide and prednisone (MPT) in relapsed/refractory multiple myeloma.

Leuk Lymphoma 2018 05 11;59(5):1271-1273. Epub 2017 Sep 11.

e Myeloma Unit, Division of Hematology , University of Torino, Azienda-Ospedaliero Universitaria Città della Salute e della Scienza di Torino , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1372575DOI Listing
May 2018

Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia.

J Clin Oncol 2014 May 14;32(14):1463-71. Epub 2014 Apr 14.

Giampaolo Bucaneve, Stelvio Ballanti, and Albano Del Favero, Ospedale S. Maria della Misericordia, Perugia, Italy; Alessandra Micozzi, Giuseppe Gentile, and Robin Foà, "Sapienza" Università di Roma, Roma; Marco Picardi, A. O. Universitaria "Federico II," Napoli; Nicola Cascavilla, Ospedale Casa Sollievo della Sofferenza, IRCCS, San Giovanni Rotondo; Prassede Salutari, Ospedale Civile "Spirito Santo," Pescara; Giorgina Specchia, Università di Bari, Bari; Rosa Fanci, A. O. Universitaria "Careggi," Firenze; Mario Luppi, A. O. Universitaria Policlinico, Modena; Laura Cudillo, Policlinico Tor Vergata, Roma; Renato Cantaffa, A. O. "Pugliese Ciaccio," Catanzaro; Giuseppe Milone, Policlinico "Vittorio Emanuele," Catania; Monica Bocchia, Policlinico "S. Maria alle Scotte," Siena; Giovanni Martinelli, Istituto Europeo Oncologico, Milano; Massimo Offidani, A. O. Universitaria-Ospedali Riuniti, Ancona; Anna Chierichini, Ospedale S. Giovanni Addolorata, Roma; Francesco Fabbiano, Ospedali Riuniti, Palermo; Giovanni Quarta, Ospedale "A. Perrino," Brindisi; Valeria Primon, Ospedale SS Antonio e Biagio, Alessandria; Bruno Martino, A. O. "Bianchi-Melacrino-Morelli," Reggio Calabria; Annunziata Manna, ASL5, La Spezia; Eliana Zuffa, Ospedale S. Maria delle Croci, Ravenna; and Antonella Ferrari, A. O. Sant'Andrea, Roma.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.6963DOI Listing
May 2014

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma.

Hematology 2012 Jan;17(1):23-7

Department of Clinical and Experimental Medicine, Section of Hematology and Clinical Immunology, University of Perugia Medical School, I-06100 Perugia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1179/102453312X13221316477534DOI Listing
January 2012

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma.

Clin Exp Med 2012 Sep 18;12(3):165-71. Epub 2011 Sep 18.

Department of Clinical and Experimental Medicine, Section of Hematology and Clinical Immunology, University of Perugia Medical School, Perugia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10238-011-0157-2DOI Listing
September 2012

Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?

Blood Rev 2011 Nov 2;25(6):247-54. Epub 2011 Jul 2.

Institute of Hematology, Strada Sant'Andrea delle Fratte, University of Perugia, 06122 Perugia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2011.06.001DOI Listing
November 2011

Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia.

Nat Clin Pract Oncol 2007 Dec;4(12):722-5

Institute of Hematology, Perugia University and IbiT Foundation, Perugia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc1008DOI Listing
December 2007

Melphalan versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for low-risk multiple myeloma.

Hematol J 2004 ;5(2):118-22

Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.thj.6200369DOI Listing
November 2004

Diagnostic considerations about visceral leishmaniasis. Two case report.

Infez Med 2002 Sep;10(3):176-8

Dipartimento Medicina Sperimentale e Scienze Biochimiche, Sezione Clinica di Malattie Infettive, Universita degli Studi di Perugia, Perugia.

View Article

Download full-text PDF

Source
September 2002